{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:24:51Z","timestamp":1792448691560,"version":"4.5.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Autoantibody production and immune complex deposition within the kidney promote renal disease in patients with lupus nephritis. Thus, therapeutics that inhibit these pathways may be efficacious in the treatment of systemic lupus erythematosus. Bruton\u2019s tyrosine kinase (BTK) is a critical signaling component of both BCR and FcR signaling. We sought to assess the efficacy of inhibiting BTK in the development of lupus-like disease, and in this article describe (R)-5-amino-1-(1-cyanopiperidin-3-yl)-3-(4-[2,4-difluorophenoxy]phenyl)-1H-pyrazole-4-carboxamide (PF-06250112), a novel highly selective and potent BTK inhibitor. We demonstrate in vitro that PF-06250112 inhibits both BCR-mediated signaling and proliferation, as well as FcR-mediated activation. To assess the therapeutic impact of BTK inhibition, we treated aged NZBxW_F1 mice with PF-06250112 and demonstrate that PF-06250112 significantly limits the spontaneous accumulation of splenic germinal center B cells and plasma cells. Correspondingly, anti-dsDNA and autoantibody levels were reduced in a dose-dependent manner. Moreover, administration of PF-06250112 prevented the development of proteinuria and improved glomerular pathology scores in all treatment groups. Strikingly, this therapeutic effect could occur with only a modest reduction observed in anti-dsDNA titers, implying a critical role for BTK signaling in disease pathogenesis beyond inhibition of autoantibody production. We subsequently demonstrate that PF-06250112 prevents proteinuria in an FcR-dependent, Ab-mediated model of glomerulonephritis. Importantly, these results highlight that BTK inhibition potently limits the development of glomerulonephritis by impacting both cell- and effector molecule-mediated pathways. These data provide support for evaluating the efficacy of BTK inhibition in systemic lupus erythematosus patients.<\/jats:p>","DOI":"10.4049\/jimmunol.1301553","type":"journal-article","created":{"date-parts":[[2013,9,26]],"date-time":"2013-09-26T00:25:46Z","timestamp":1380155146000},"page":"4540-4550","source":"Crossref","is-referenced-by-count":103,"title":["Selective Inhibition of BTK Prevents Murine Lupus and Antibody-Mediated Glomerulonephritis"],"prefix":"10.1093","volume":"191","author":[{"given":"Andrew L","family":"Rankin","sequence":"first","affiliation":[{"name":"Immunoscience, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilufer","family":"Seth","sequence":"additional","affiliation":[{"name":"Immunoscience, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Keegan","sequence":"additional","affiliation":[{"name":"Immunoscience, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Andreyeva","sequence":"additional","affiliation":[{"name":"Immunoscience, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim A","family":"Cook","sequence":"additional","affiliation":[{"name":"Immunoscience, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Edmonds","sequence":"additional","affiliation":[{"name":"Immunoscience, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagappan","family":"Mathialagan","sequence":"additional","affiliation":[{"name":"Drug Safety Research and Development, Pfizer Research , Groton, CT 06340"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah J","family":"Benson","sequence":"additional","affiliation":[{"name":"Immunoscience, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jameel","family":"Syed","sequence":"additional","affiliation":[{"name":"Drug Safety Research and Development, Pfizer Research , Andover, MA 01810"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutian","family":"Zhan","sequence":"additional","affiliation":[{"name":"Drug Safety Research and Development, Pfizer Research , Andover, MA 01810"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E","family":"Benoit","sequence":"additional","affiliation":[{"name":"Precision Medicine, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy S","family":"Miyashiro","sequence":"additional","affiliation":[{"name":"Immunoscience, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Wood","sequence":"additional","affiliation":[{"name":"Immunoscience, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi","family":"Mohan","sequence":"additional","affiliation":[{"name":"Immunoscience, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Peeva","sequence":"additional","affiliation":[{"name":"Precision Medicine, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi K","family":"Ramaiah","sequence":"additional","affiliation":[{"name":"Drug Safety Research and Development, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean","family":"Messing","sequence":"additional","affiliation":[{"name":"Pharmacokinetics, Dynamics and Metabolism, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce L","family":"Homer","sequence":"additional","affiliation":[{"name":"Drug Safety Research and Development, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyri","family":"Dunussi-Joannopoulos","sequence":"additional","affiliation":[{"name":"Immunoscience, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl L","family":"Nickerson-Nutter","sequence":"additional","affiliation":[{"name":"Immunoscience, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E","family":"Schnute","sequence":"additional","affiliation":[{"name":"Medicinal Chemistry, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"John","family":"Douhan","sequence":"additional","affiliation":[{"name":"Immunoscience, Pfizer Research , Cambridge, MA 02140"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,11,1]]},"reference":[{"key":"2025032405512864400_r1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.coi.2012.10.004","article-title":"The pathogenesis of systemic lupus erythematosus-an update","volume":"24","author":"Choi","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"2025032405512864400_r2","doi-asserted-by":"crossref","first-page":"7154","DOI":"10.4049\/jimmunol.0902514","article-title":"Lupus serum IgG induces skin inflammation through the TNFR1 signaling pathway","volume":"184","author":"Deng","year":"2010","journal-title":"J. Immunol."},{"key":"2025032405512864400_r3","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJM198202043060503","article-title":"Cutaneous localization of the membrane attack complex in discoid and systemic lupus erythematosus","volume":"306","author":"Biesecker","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"2025032405512864400_r4","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1084\/jem.154.6.1779","article-title":"Renal localization of the membrane attack complex in systemic lupus erythematosus nephritis","volume":"154","author":"Biesecker","year":"1981","journal-title":"J. Exp. Med."},{"key":"2025032405512864400_r5","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.4049\/jimmunol.142.9.3076","article-title":"Anti-DNA antibodies bind directly to renal antigens and induce kidney dysfunction in the isolated perfused rat kidney","volume":"142","author":"Raz","year":"1989","journal-title":"J. Immunol."},{"key":"2025032405512864400_r6","doi-asserted-by":"crossref","first-page":"7287","DOI":"10.4049\/jimmunol.177.10.7287","article-title":"FcR-bearing myeloid cells are responsible for triggering murine lupus nephritis","volume":"177","author":"Bergtold","year":"2006","journal-title":"J. Immunol."},{"key":"2025032405512864400_r7","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1126\/science.279.5353.1052","article-title":"Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis","volume":"279","author":"Clynes","year":"1998","journal-title":"Science"},{"key":"2025032405512864400_r8","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.4049\/jimmunol.0901301","article-title":"Both complement and IgG fc receptors are required for development of attenuated antiglomerular basement membrane nephritis in mice","volume":"183","author":"Otten","year":"2009","journal-title":"J. Immunol."},{"key":"2025032405512864400_r9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.4049\/jimmunol.152.2.557","article-title":"Expression of Bruton\u2019s agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells","volume":"152","author":"Smith","year":"1994","journal-title":"J. Immunol."},{"key":"2025032405512864400_r10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/0952-7915(94)90151-1","article-title":"Role of Bruton\u2019s tyrosine kinase in immunodeficiency","volume":"6","author":"Tsukada","year":"1994","journal-title":"Curr. Opin. Immunol."},{"key":"2025032405512864400_r11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0065-2776(07)96005-8","article-title":"Fc-receptors as regulators of immunity","volume":"96","author":"Nimmerjahn","year":"2007","journal-title":"Adv. Immunol."},{"key":"2025032405512864400_r12","doi-asserted-by":"crossref","first-page":"8152","DOI":"10.1073\/pnas.91.17.8152","article-title":"Binding of Bruton\u2019s tyrosine kinase to Fyn, Lyn, or Hck through a Src homology 3 domain-mediated interaction","volume":"91","author":"Cheng","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032405512864400_r13","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S1074-7613(00)80417-3","article-title":"Regulation of Btk function by a major autophosphorylation site within the SH3 domain","volume":"4","author":"Park","year":"1996","journal-title":"Immunity"},{"key":"2025032405512864400_r14","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1084\/jem.191.10.1735","article-title":"Bruton\u2019s tyrosine kinase links the B cell receptor to nuclear factor kappaB activation","volume":"191","author":"Bajpai","year":"2000","journal-title":"J. Exp. Med."},{"key":"2025032405512864400_r15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0014-4827(03)00338-0","article-title":"B cell receptor directs the activation of NFAT and NF-kappaB via distinct molecular mechanisms","volume":"291","author":"Antony","year":"2003","journal-title":"Exp. Cell Res."},{"key":"2025032405512864400_r16","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1084\/jem.187.7.1081","article-title":"Transgene expression of bcl-xL permits anti-immunoglobulin (Ig)-induced proliferation in xid B cells","volume":"187","author":"Solvason","year":"1998","journal-title":"J. Exp. Med."},{"key":"2025032405512864400_r17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nchembio.481","article-title":"Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis","volume":"7","author":"Di Paolo","year":"2011","journal-title":"Nat. Chem. Biol."},{"key":"2025032405512864400_r18","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.4049\/jimmunol.1003871","article-title":"IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL\/MpJ-Fas(lpr\/lpr)\/J mice","volume":"188","author":"Rankin","year":"2012","journal-title":"J. Immunol."},{"key":"2025032405512864400_r19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/1074-7613(95)90114-0","article-title":"Defective B cell development and function in Btk-deficient mice","volume":"3","author":"Khan","year":"1995","journal-title":"Immunity"},{"key":"2025032405512864400_r20","doi-asserted-by":"crossref","first-page":"15595","DOI":"10.1074\/jbc.272.25.15595","article-title":"Transphosphorylation of Bruton\u2019s tyrosine kinase on tyrosine 551 is critical for B cell antigen receptor function","volume":"272","author":"Kurosaki","year":"1997","journal-title":"J. Biol. Chem."},{"key":"2025032405512864400_r21","doi-asserted-by":"crossref","first-page":"37651","DOI":"10.1074\/jbc.M311985200","article-title":"Tec kinases mediate sustained calcium influx via site-specific tyrosine phosphorylation of the phospholipase Cgamma Src homology 2-Src homology 3 linker","volume":"279","author":"Humphries","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2025032405512864400_r22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/cmdc.200600221","article-title":"Discovery of selective irreversible inhibitors for Bruton\u2019s tyrosine kinase","volume":"2","author":"Pan","year":"2007","journal-title":"ChemMedChem"},{"key":"2025032405512864400_r23"},{"key":"2025032405512864400_r24","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1084\/jem.187.8.1235","article-title":"Involvement of Bruton\u2019s tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production","volume":"187","author":"Hata","year":"1998","journal-title":"J. Exp. Med."},{"key":"2025032405512864400_r25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.intimp.2010.12.018","article-title":"Inhibition of IgE-mediated secretion from human basophils with a highly selective Bruton\u2019s tyrosine kinase, Btk, inhibitor","volume":"11","author":"MacGlashan","year":"2011","journal-title":"Int. Immunopharmacol."},{"key":"2025032405512864400_r26","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0065-2776(08)60342-9","article-title":"Murine models of systemic lupus erythematosus","volume":"37","author":"Theofilopoulos","year":"1985","journal-title":"Adv. Immunol."},{"key":"2025032405512864400_r27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1172\/JCI9244","article-title":"CTLA4Ig inhibits T cell-dependent B-cell maturation in murine systemic lupus erythematosus","volume":"106","author":"Mihara","year":"2000","journal-title":"J. Clin. Invest."},{"key":"2025032405512864400_r28","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1172\/JCI110651","article-title":"Ability of the xid gene to prevent autoimmunity in (NZB X NZW)F1 mice during the course of their natural history, after polyclonal stimulation, or following immunization with DNA","volume":"70","author":"Steinberg","year":"1982","journal-title":"J. Clin. Invest."},{"key":"2025032405512864400_r29","doi-asserted-by":"crossref","first-page":"13152","DOI":"10.1073\/pnas.94.24.13152","article-title":"Btk dosage determines sensitivity to B cell antigen receptor cross-linking","volume":"94","author":"Satterthwaite","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2025032405512864400_r30","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1182\/blood-2011-12-397919","article-title":"Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice","volume":"119","author":"Kil","year":"2012","journal-title":"Blood"},{"key":"2025032405512864400_r31","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.4049\/jimmunol.180.3.1938","article-title":"Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis","volume":"180","author":"Schiffer","year":"2008","journal-title":"J. Immunol."},{"key":"2025032405512864400_r32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1523-1755.1998.00978.x","article-title":"Local macrophage proliferation in human glomerulonephritis","volume":"54","author":"Yang","year":"1998","journal-title":"Kidney Int."},{"key":"2025032405512864400_r33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ki.1990.14","article-title":"Lupus nephritis: correlation of interstitial cells with glomerular function","volume":"37","author":"Alexopoulos","year":"1990","journal-title":"Kidney Int."},{"key":"2025032405512864400_r34","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1172\/JCI42213","article-title":"The proteoglycan biglycan regulates expression of the B cell chemoattractant CXCL13 and aggravates murine lupus nephritis","volume":"120","author":"Moreth","year":"2010","journal-title":"J. Clin. Invest."},{"key":"2025032405512864400_r35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.1523-1755.2003.00717.x","article-title":"Adoptive transfer studies demonstrate that macrophages can induce proteinuria and mesangial cell proliferation","volume":"63","author":"Ikezumi","year":"2003","journal-title":"Kidney Int."},{"key":"2025032405512864400_r36","doi-asserted-by":"crossref","first-page":"21537","DOI":"10.1074\/jbc.M201903200","article-title":"Chemotactic factor-induced recruitment and activation of Tec family kinases in human neutrophils. Implication of phosphatidynositol 3-kinases","volume":"277","author":"Lachance","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2025032405512864400_r37","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/j.1523-1755.2005.00279.x","article-title":"Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis","volume":"67","author":"Khan","year":"2005","journal-title":"Kidney Int."},{"key":"2025032405512864400_r38","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1084\/jem.189.10.1639","article-title":"A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus","volume":"189","author":"Chan","year":"1999","journal-title":"J. Exp. Med."},{"key":"2025032405512864400_r39","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/art.10813","article-title":"Fc receptor-independent development of autoimmune glomerulonephritis in lupus-prone MRL\/lpr mice","volume":"48","author":"Matsumoto","year":"2003","journal-title":"Arthritis Rheum."},{"key":"2025032405512864400_r40"},{"key":"2025032405512864400_r41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1124\/jpet.111.187740","article-title":"RN486, a selective Bruton\u2019s tyrosine kinase inhibitor, abrogates immune hypersensitivity responses and arthritis in rodents","volume":"341","author":"Xu","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"2025032405512864400_r42","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1084\/jem.192.11.1611","article-title":"Severe B cell deficiency in mice lacking the tec kinase family members Tec and Btk","volume":"192","author":"Ellmeier","year":"2000","journal-title":"J. Exp. Med."},{"key":"2025032405512864400_r43","doi-asserted-by":"crossref","first-page":"a002287","DOI":"10.1101\/cshperspect.a002287","article-title":"T-cell signaling regulated by the Tec family kinase, Itk","volume":"2","author":"Andreotti","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"2025032405512864400_r44","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1126\/science.284.5414.638","article-title":"Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity","volume":"284","author":"Schaeffer","year":"1999","journal-title":"Science"},{"key":"2025032405512864400_r45","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.27515","article-title":"Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus","volume":"62","author":"Bekar","year":"2010","journal-title":"Arthritis Rheum."},{"key":"2025032405512864400_r46","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4049\/jimmunol.182.1.329","article-title":"Btk regulates B cell receptor-mediated antigen processing and presentation by controlling actin cytoskeleton dynamics in B cells","volume":"182","author":"Sharma","year":"2009","journal-title":"J. Immunol."},{"key":"2025032405512864400_r47","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/ni.2015","article-title":"Intracellular MHC class II molecules promote TLR-triggered innate immune responses by maintaining activation of the kinase Btk","volume":"12","author":"Liu","year":"2011","journal-title":"Nat. Immunol."},{"key":"2025032405512864400_r48","first-page":"181","article-title":"Defective Fc-, CR1- and CR3-mediated monocyte phagocytosis and chemotaxis in common variable immunodeficiency and X-linked agammaglobulinemia patients","volume":"13","author":"Amoras","year":"2003","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"2025032405512864400_r49","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4049\/jimmunol.181.1.288","article-title":"Dual functions of Bruton\u2019s tyrosine kinase and Tec kinase during Fcgamma receptor-induced signaling and phagocytosis","volume":"181","author":"Jongstra-Bilen","year":"2008","journal-title":"J. Immunol."},{"key":"2025032405512864400_r50","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1084\/jem.149.4.993","article-title":"Immunoglobulin subclass-specific immunodeficiency in mice with an X-linked B-lymphocyte defect","volume":"149","author":"Perlmutter","year":"1979","journal-title":"J. Exp. Med."}],"container-title":["The Journal of Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/191\/9\/4540\/62509832\/1301553.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jimmunol\/article-pdf\/191\/9\/4540\/62509832\/1301553.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T03:58:06Z","timestamp":1742875086000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jimmunol\/article\/191\/9\/4540\/7989603"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,1]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,11,1]]}},"URL":"https:\/\/doi.org\/10.4049\/jimmunol.1301553","relation":{},"ISSN":["0022-1767","1550-6606"],"issn-type":[{"value":"0022-1767","type":"print"},{"value":"1550-6606","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,11]]},"published":{"date-parts":[[2013,11,1]]}}}